Effect Of Nintedanib On Decline In Forced Vital Capacity (Fvc) In Patients With Progressive Fibrosing Interstitial Lung Diseases (Ilds) By Time Since Diagnosis

M. E. Strek, R. W. Hallowell,J. Kus,H. Nunes,T. Suda,S. Tomassetti,H. Mueller, K. B. Rohr, K. R. Flaherty

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2021）

引用 0|浏览1

暂无评分

摘要

Rationale In the INBUILD trial in patients with chronic fibrosing ILDs with a progressive phenotype (other than idiopathic pulmonary fibrosis [IPF]), nintedanib slowed the rate

查看译文

关键词

interstitial lung diseases,lung diseases,nintedanib,forced vital capacity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要